Barely Significant
← all excerpts

Trabectedin in soft tissue sarcomas.

Mar Drugs · 2015 · PMC4344612 · PMID 25686274

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

a strong trendno p-value reported
No significant difference in overall survival was observed between the two arms of the trial; however, there was a strong trend favoring the 24-h infusion schedule (13.9 months vs. 11.8 months).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.